The impact of volume substitution on post-operative atrial fibrillation.


Journal

European journal of clinical investigation
ISSN: 1365-2362
Titre abrégé: Eur J Clin Invest
Pays: England
ID NLM: 0245331

Informations de publication

Date de publication:
May 2021
Historique:
revised: 29 09 2020
received: 27 07 2020
accepted: 05 11 2020
pubmed: 21 11 2020
medline: 15 12 2021
entrez: 20 11 2020
Statut: ppublish

Résumé

Post-operative atrial fibrillation (POAF) represents a common complication after cardiac valve or coronary artery bypass surgery. While strain of atrial tissue is known to induce atrial fibrillating impulses, less attention has been paid to potentially strain-promoting values during the peri- and post-operative period. This study aimed to determine the association of peri- and post-operative volume substitution with markers of cardiac strain and subsequently the impact on POAF development and promotion. A total of 123 (45.4%) individuals were found to develop POAF. Fluid balance within the first 24 hours after surgery was significantly higher in patients developing POAF as compared to non-POAF individuals (+1129.6 mL [POAF] vs +544.9 mL [non-POAF], P = .044). Post-operative fluid balance showed a direct and significant correlation with post-operative N-terminal pro-brain natriuretic peptide (NT-ProBNP) values (r = .287; P = .002). Of note, the amount of substituted volume significantly proved to be a strong and independent predictor for POAF with an adjusted odds ratio per one litre of 1.44 (95% CI: 1.09-1.31; P = .009). In addition, we observed that low pre-operative haemoglobin levels at admission were associated with a higher need of intraoperative transfusions and volume-demand. Substitution of larger transfusion volumes presents a strong and independent predictor for the development of POAF. Via the observed distinct association with NT-proBNP values, it can reasonably be assumed that post-operative atrial fibrillating impulses are triggered via increased global cardiac strain. Optimized pre-operative management of pre-existing anaemia should be considered prior surgical intervention in terms of a personalized patient care.

Sections du résumé

BACKGROUND BACKGROUND
Post-operative atrial fibrillation (POAF) represents a common complication after cardiac valve or coronary artery bypass surgery. While strain of atrial tissue is known to induce atrial fibrillating impulses, less attention has been paid to potentially strain-promoting values during the peri- and post-operative period. This study aimed to determine the association of peri- and post-operative volume substitution with markers of cardiac strain and subsequently the impact on POAF development and promotion.
RESULTS RESULTS
A total of 123 (45.4%) individuals were found to develop POAF. Fluid balance within the first 24 hours after surgery was significantly higher in patients developing POAF as compared to non-POAF individuals (+1129.6 mL [POAF] vs +544.9 mL [non-POAF], P = .044). Post-operative fluid balance showed a direct and significant correlation with post-operative N-terminal pro-brain natriuretic peptide (NT-ProBNP) values (r = .287; P = .002). Of note, the amount of substituted volume significantly proved to be a strong and independent predictor for POAF with an adjusted odds ratio per one litre of 1.44 (95% CI: 1.09-1.31; P = .009). In addition, we observed that low pre-operative haemoglobin levels at admission were associated with a higher need of intraoperative transfusions and volume-demand.
CONCLUSION CONCLUSIONS
Substitution of larger transfusion volumes presents a strong and independent predictor for the development of POAF. Via the observed distinct association with NT-proBNP values, it can reasonably be assumed that post-operative atrial fibrillating impulses are triggered via increased global cardiac strain. Optimized pre-operative management of pre-existing anaemia should be considered prior surgical intervention in terms of a personalized patient care.

Identifiants

pubmed: 33215691
doi: 10.1111/eci.13456
pmc: PMC8244026
doi:

Substances chimiques

Hemoglobins 0
Peptide Fragments 0
pro-brain natriuretic peptide (1-76) 0
Natriuretic Peptide, Brain 114471-18-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13456

Informations de copyright

© 2020 The Authors. European Journal of Clinical Investigation published by John Wiley & Sons Ltd on behalf of Stichting European Society for Clinical Investigation Journal Foundation.

Références

Clin Cardiol. 2014 Jan;37(1):7-13
pubmed: 24353215
Am J Emerg Med. 2016 Aug;34(8):1480-5
pubmed: 27260556
Eur J Heart Fail. 2017 Feb;19(2):167-176
pubmed: 27766748
Circ J. 2015;79(1):70-6
pubmed: 25482295
Circ J. 2013;77(9):2303-10
pubmed: 23979566
Eur Heart J. 2016 Oct 7;37(38):2893-2962
pubmed: 27567408
Eur J Clin Invest. 2015 Feb;45(2):170-8
pubmed: 25510286
Ann Thorac Surg. 2014 Aug;98(2):527-33; discussion 533
pubmed: 25087786
Interact Cardiovasc Thorac Surg. 2016 Feb;22(2):176-80
pubmed: 26598007
Ann Thorac Surg. 2012 Aug;94(2):460-7
pubmed: 22626751
Interact Cardiovasc Thorac Surg. 2016 Aug;23(2):326-8
pubmed: 27165734
Eur J Clin Invest. 2021 May;51(5):e13456
pubmed: 33215691
Lancet. 2003 Jul 26;362(9380):316-22
pubmed: 12892964
Front Cardiovasc Med. 2018 Dec 21;5:178
pubmed: 30619885
J Cardiothorac Vasc Anesth. 2010 Dec;24(6):952-8
pubmed: 20570180
J Cardiovasc Med (Hagerstown). 2014 Mar;15(3):199-206
pubmed: 24572338
Int J Cardiol. 2014 Jan 15;171(1):44-8
pubmed: 24315351
Ann Thorac Surg. 2017 Jan;103(1):92-97
pubmed: 27577036
Blood Transfus. 2012 Oct;10(4):490-501
pubmed: 22395355
J Thorac Cardiovasc Surg. 2013 Jul;146(1):114-8
pubmed: 22841168
Am Heart J. 2014 Apr;167(4):593-600.e1
pubmed: 24655710
Scand J Surg. 2013;102(2):110-6
pubmed: 23820687
World J Surg. 2014 Jan;38(1):51-9
pubmed: 24129801
J Cardiothorac Vasc Anesth. 2016 Apr;30(2):413-7
pubmed: 26706710
Heart Rhythm. 2014 Jul;11(7):1156-62
pubmed: 24657803
Turk Kardiyol Dern Ars. 2016 Jan;44(1):45-52
pubmed: 26875130
J Crit Care. 2012 Dec;27(6):737.e1-9
pubmed: 22762927
PLoS One. 2015 Apr 17;10(4):e0124716
pubmed: 25884835
Heart Lung Circ. 2016 Oct;25(10):993-9
pubmed: 27011039

Auteurs

Sebastian Schnaubelt (S)

Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria.

Arnold Pilz (A)

Department of Respiratory Medicine, Otto Wagner Hospital, Vienna, Austria.

Lorenz Koller (L)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Niema Kazem (N)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Felix Hofer (F)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Tatjana Fleck (T)

Division of Cardiac Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria.

Günther Laufer (G)

Division of Cardiac Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria.

Barbara Steinlechner (B)

Department of Anesthesia, Intensive Care and Pain Management, Medical University of Vienna, Vienna, Austria.

Alexander Niessner (A)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Patrick Sulzgruber (P)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH